National Cardiogenic Shock Initiative (CSI) Protocol

Sites participating in the National Cardiogenic Shock Initiative (CSI) have adopted the National CSI algorithm as the foundatio...

Published Investigator-led Studies for AMI Cardiogenic Shock

IMP-1524...

Large Intracardiac Thrombus in COVID-19 Patient Managed with Percutaneous Thrombectomy and Right Ventricular Support

IMP-1432 v2...

The Opportunity for Increased Quality of Care and Shared Savings With the lmpella® Heart Pump

It is possible that new, minimally invasive technologies, such as the lmpella pVAD, can provide the opportunity to concomitantl...

The Benefit and Efficacy of Complete Revascularization in a Single Setting

Read more about comprehensive and well-documented data that demonstrates how complete revascularization has distinct clinical a...

Renal Protection During Impella®-Supported PCI in Patients With High-Risk Complex Coronary Artery Disease

Protected PCI with Impella lowers the incidence of AKI when compared to high-risk PCI in ECMO-supported patients and demonstrat...

Evolving Evidence for Protected PCI with Impella to Treat High-Risk Complex CAD Patients

Results from the PROTECT clinical studies consistently demonstrate a reduction in MACCE at 90 days after Protected PCI with the...

Current PCI Landscape and Opportunities for Improvement

An overview of the landscape, contemporary data, quality measures, and technological trends that will guide complex CAD cases t...

Using Impella CP® with SmartAssist® to Guide Successful Weaning in High-Risk PCI Procedure

IMP-1360...

Impella 5.5 TTE and TEE Position Summary Guides

IMP-1235...

Impella TTE and TEE Position Summary Guides

IMP-046 v2...

CRT 2020 Cardiogenic Shock Overview: Understanding Recent Clinical Data

Single-Access with 14 F Impella Sheath Procedural Steps

Abiomed’s Impella CP Introducer* was recently FDA cleared1 , and is being released to users. It has a 14 French (F)...

High-Risk PCI Involving Chronic Kidney Disease, PVD and LV-dysfunction

Dr. Flaherty presents a case review of an 85-year-old male who presented with unstable angina symptoms, multivessel coronary ar...

Clinical Dossier Protected PCI with Impella®

The 2020 Clinical Dossier: Protected PCI with Impella® is a collection of data and clinical evidence supporting the use of Impe...

Impella Protects Against AKI in HRPCI

With Impella support in high-risk PCI, overall incidence of post-procedural AKI is significantly re...

Protected PCI Scientific Overview

IMP-1015-16 v7...

WellStar Hub and Spoke Cardiogenic Shock Treatment Network

Successful Implementation of Cardiogenic Shock Algorithm Dr. Salvatore Mannino discusses the...

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study...

PROTECT III Data Demonstrates Impella® Reduces MACCE Compared to IABP

NPS-420...

Impella Patient Systemic IV Heparin Rate Calculator

Anticoagulation Therapy with Impella® Heparin Infusion NPS-359 v3...

Allegheny Health Network Protected PCI Algorithm

Download the Allegheny Health Network Protected PCI Algorithm to guide decision-making for appropriate use of the Impella® hear...

New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery

New data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients...

Hub-Spoke Patient Transfer Packet

Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device  from the "...

For Best Outcomes in AMI Cardiogenic Shock, Place Impella 2.5® or Impella CP® Pre-PCI

A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...

Impella RP® Heart Pump Patient Selection Criteria Checklist

Use this checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-796 v3...

Impella Updates – Reaccess Sheath

This sheath enables reaccess to the artery for the duration of Impella support with up to an 0.035” guidewire. The additional s...

Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

Renal Effects of Impella Support During Protected PCI

Dr. Michael P. Flaherty's TCT 2018 presentation on Renal Effects of Impella support during Protected PCI....

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) data...

Sentara Heart Hospital PCI Algorithm

IMP-287-17 v3...

Step-by-Step Guide to Left Heart Unloading with Impella 5.0®

The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...

Step-by-Step Guide to Right Heart Unloading with Impella RP®

The Impella RP is the only FDA approved support device for the treatment of right heart failure....

Mt. Sinai Protected PCI Algorithm

Download the Mt. Sinai Protected PCI Algorithm to guide decision-making for appropriate use of the Impella 2.5 and Impella CP h...

Impella Quick Reference and Troubleshooting Guide

Impella 2.5/Impella CP/Impella 5.0/Impella LD/Impella RP Heart Pumps - Quick Reference and Troubleshooting Guide For AIC Softwa...

WVU Heart & Vascular Institute’s high-risk PCI algorithm

Download the WVU Heart & Vascular Institute Complete Revascularization of Complex and High Risk Coronary Artery Disease Alg...

Complex PCI with Multiple Comorbidities

Dr. Tanveer Rab of Emory University joins Dr. Cathy Jeon to discuss a case of an 80 year old male with a low ejection fraction...

Protected PCI Coordinator Program Implementation Plan

IMP-225-17 v4...

Impella Flow Sheet

AIC-027-17 v2...

Job Specific Competency – Coordinators

IM2-271-16 v5...

Clinical Guidelines For Impella Devices

IMP-1347-16 v8...

Atkinson Algorithm

Abiomed’s Cardiogenic Shock Guidelines

The use of standardized protocols has been associated with improvement in outcomes for people in...

Henry Ford Algorithm

This is a sample high-risk PCI algorithm used by Henry Ford Health System. Specifically, it is a Left Ventricular Mechanical Ci...

University Hospitals Cleveland Medical Center Protected PCI Algorithm

IMP-037-17 v3...

INOVA Heart and Vascular Institute Protected PCI Algorithm

Download INOVA Heart and Vascular Institute’s Protected PCI algorithm, which begins with a heart team evaluation of high risk c...

Einstein Protected PCI Algorithm

IM2-274-16 v2...

Impella® Program Protocol and Tools

The Impella® Program Protocol and Tools Provides Resources on Impella Best Practices Including:Data-driven protoc...

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  FDA i...

Estimating Impella 5.0/LD Flow from Motor Current

Abiomed has observed that when clinicians encounter an unreliable differential pressure sensor while a patient is being support...

The Science of Hemodynamic Support

NPS-096-16 v7...

Impella Updates – Femoral Access Site Management

Recommendation for maintaining initial insertion site angle with the Impella 2.5 and Impella CP heart pumps IMP-1129-16...

Venn Shock Card

Reference card for determining which patients benefit from Impella and the hemodynamic effects of Impella support. NPS-2...